AssessmentsAnticonvulsants and anxiolytics: Benzodiazepines
Anticonvulsants and anxiolytics: Benzodiazepines
The preferred pharmacologic management of panic disorder consists of benzodiazepines for acute management and (medication class) or venlafaxine for long-term options.
USMLE® Step 1 style questions USMLE
USMLE® Step 2 style questions USMLE
A 71 year-old female presents the emergency department with her husband who reports the patient is confused and disoriented. History reveals the patient woke up that morning not knowing where she was and did not remember what had happened the day before. She had recently started a new medication by her internist. Physical examination reveals the patient is oriented to self and place. A neurologic examination is unremarkable. Which of the following medications would most likely cause this cognitive impairment?
Benzodiazepines are a class of medications that act as a central nervous system depressant.
They have a wide variety of uses including anxiolytic effects, or to relieve anxiety; as anticonvulsants, or to manage seizure disorders; as a hypnotic for insomnia; as an anesthetic; and to treat withdrawal syndromes.
They act by enhancing the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, by binding to its receptor.
It’s pretty well-established that your brain’s really important.
It controls your feelings, your movements, your sleep, your memory… It controls everything, whether you’re aware of it or not.
The cells that make up our brain are called neurons.
Neurons communicate with each other through neurotransmitters.
When one neuron is stimulated, it’ll release excitatory neurotransmitters like glutamate which bind to receptors on the next neuron.
This causes the next neuron to depolarize and release its own excitatory neurotransmitters, propagating the signal throughout the brain.
Now, we also have inhibitory neurons that will shut down this chain of events.
These neurons release the main inhibitory neurotransmitter gamma-aminobutyric acid, or GABA, which binds to GABA receptors on other neurons.
These receptors are large, multi unit complexes that form ligand-gated ion channels that open up to let Cl- ions into the cell.
The influx of negatively charged ions causes hyperpolarization, where the cell’s membrane potential becomes more negative, which means it’s much more difficult for it to depolarize and fire off an action potential, meaning it’s less responsive to stimuli.
Alright, now there are cases where neurons in the brain start sending out more excitatory signals than normal.
This can occur due to either too much excitation by the excitatory neurotransmitters, or too little inhibition by the inhibitory neurotransmitters like GABA.
Okay, so one way we can decrease the excitatory signals is by enhancing the effect of inhibitory neurons through medication like benzodiazepines.
They are composed of a benzene ring that consists of six carbon atoms fused to a diazepine ring that is made up of 5 carbon atoms and two nitrogen atoms.
Now, based on the overall duration of action, these medications can be subdivided into short-acting benzodiazepines, like ALPRAZolam, Triazolam, Oxazepam, and Midazolam; intermediate-acting benzodiazepines, such as Temazepam, LORazepam, and ClonazePAM; and finally, long-acting benzodiazepines, like ChlordiazePOXIDE, DiazePAM, and Flurazepam.
So, to remember short-acting benzodiazepines think of “ATOM”; for intermediate-acting, remember that these medications are tender, loving, and caring, or short TLC; and finally for long-acting benzodiazepines, think of alphabet and it’s order CDeF.
These medications target the BZ site of GABAA receptors, which is located between ⍺1 and 𝛾2 subunits of the receptor.
As a result, high intracellular concentrations of Cl- ions cause membrane hyperpolarization, which means it’s much more difficult for neuron to depolarize and fire off an action potential.
Now, a similar group of medications called barbiturates also function by binding to GABAA receptors.
Now, let’s draw a chart of the dose-dependent effects of benzodiazepines.
On the left side of the chart, let’s place central nervous effects and on the bottom, let’s place dose.
It’s important to note that preferred medications for the long-term treatment of panic attacks are selective serotonin reuptake inhibitors, or short SSRIs, due to abuse potential, dependence, and tolerance of benzodiazepines.
Benzodiazepines are also very effective anticonvulsants and are considered the treatment of choice for status epilepticus, which is when a person has over 5 minutes of ongoing seizures or multiple seizures without returning to normal in between.
For the same reason, they are an effective treatment for insomnia, but they decrease REM sleep.
Moreover, because they decrease REM sleep, they can also be used to treat night terrors, which is a sleep disorder similar to nightmares but far more dramatic as it’s associated with screaming and crying.
They can cause drowsiness, as well as a decrease in concentration, problem solving abilities, and reaction time.
Due to this, they should not be taken before driving.
Despite being a central nervous system depressant, benzodiazepines can cause paradoxical stimulation in certain parts of the brain, leading to symptoms such as fast speech, excitement, and restlessness.
Another side effect is anterograde amnesia, which is defined as an inability to form new memories after the administration of the medication.
Next, benzodiazepines should be used with caution in the elderly because they can cause ataxia and precipitate falls.
Also when combined with alcohol or other medications that depress the central nervous system, like barbiturates, the depressive effects are additive and can get severe to the point of respiratory depression and coma.
- "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
- "Rang and Dale's Pharmacology" Elsevier (2019)
- "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
- "Long-, intermediate- and short-acting benzodiazepine effects on human sleep EEG spectra" Psychiatry and Clinical Neurosciences (2003)
- "Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam" Clin Pharmacol Ther (1986)
- "Short acting benzodiazepines" BMJ (1993)
- "Treatment of Benzodiazepine Dependence" N Engl J Med (2017)